Enhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular Salmonella
暂无分享,去创建一个
Yanfei Tao | Dongmei Chen | Yuanhu Pan | Lingli Huang | Shuyu Xie | Y. Tao | Yuanhu Pan | Wei Qu | Lingli Huang | Dongmei Chen | Zhenli Liu | Zonghui Yuan | Shuyu Xie | Wei Qu | Zhenli Liu | Zonghui Yuan | Fei Yang | Fei Yang
[1] J. M. Lanao,et al. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[2] K. Kisich,et al. Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. , 2007, International journal of pharmaceutics.
[3] F. Bonini,et al. Ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: pharmacokinetics and in vitro antimicrobial activity , 1998 .
[4] M. Çorlu,et al. Determination of intracellular concentrations of free and two types of liposome-encapsulated enrofloxacin in anatolian shepherd dog monocytes. , 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.
[5] A. Pardakhty,et al. Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation , 2013, Journal of Nanoparticle Research.
[6] D. Chakravortty,et al. Visiting the cell biology of Salmonella infection. , 2010, Microbes and infection.
[7] Yanfei Tao,et al. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[8] Y. Oh,et al. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.
[9] T. Seki,et al. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes , 2006, Journal of drug targeting.
[10] A. L. Baş,et al. Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish Shepherd Dog neutrophils in vitro , 2000 .
[11] R. Schwendener,et al. The effects of charge and size on the interaction of unilamellar liposomes with macrophages. , 1984, Biochimica et biophysica acta.
[12] T. Seki,et al. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification , 2007, The Journal of pharmacy and pharmacology.
[13] A. Rigotti,et al. The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*) , 1995, The Journal of Biological Chemistry.
[14] Y Ikada,et al. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. , 1988, Biomaterials.
[15] M. Tobin-D'Angelo,et al. Estimates of enteric illness attributable to contact with animals and their environments in the United States. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] D. Boothe,et al. Time course of enrofloxacin and its active metabolite in peripheral leukocytes of dogs. , 2001, Veterinary therapeutics : research in applied veterinary medicine.
[17] Samuel I. Miller,et al. Salmonellae interplay with host cells , 2008, Nature Reviews Microbiology.
[18] M. Woodward,et al. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig. , 2004, The Journal of antimicrobial chemotherapy.
[19] P. Couvreur,et al. Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.
[20] S. Bosch,et al. Salmonellosis and Meat Purchased at Live-Bird and Animal-Slaughter Markets, United States, 2007–2012 , 2014, Emerging infectious diseases.
[21] T. Niewold,et al. Effects of Enrofloxacin on Porcine Phagocytic Function , 1999, Antimicrobial Agents and Chemotherapy.
[22] A. L. Baş,et al. Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro. , 2005, DTW. Deutsche tierarztliche Wochenschrift.
[23] Z. Değim,et al. The use of liposomal enrofloxacin for intracellular infections in Kangal dogs and visualization of phagocytosis of liposomes. , 2002, Journal of biomedical materials research.
[24] Wenzhong Zhou,et al. Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids. , 2011, Colloids and surfaces. B, Biointerfaces.
[25] S. Ferrari,et al. Author contributions , 2021 .